加利福尼亚北部综合医疗系统中成年人 SARS-CoV-2 感染检测后 30 天静脉血栓栓塞发生率。
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California.
机构信息
Division of Research, Kaiser Permanente Northern California, Oakland.
The Permanente Medical Group, Kaiser Permanente Northern California.
出版信息
JAMA Intern Med. 2021 Jul 1;181(7):997-1000. doi: 10.1001/jamainternmed.2021.0488.
Abstract
This cohort study examines the 30-day incidence of outpatient and hospital-associated venous thromboembolism following SARS-CoV-2 testing among adults in a large health system.
摘要
这项队列研究调查了在一个大型医疗系统中，成年人在接受 SARS-CoV-2 检测后 30 天内门诊和医院相关静脉血栓栓塞的发生率。
相似文献
1
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California.加利福尼亚北部综合医疗系统中成年人 SARS-CoV-2 感染检测后 30 天静脉血栓栓塞发生率。
JAMA Intern Med. 2021 Jul 1;181(7):997-1000. doi: 10.1001/jamainternmed.2021.0488.
2
ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.ABO血型、新型冠状病毒2019感染与静脉血栓栓塞风险：基于人群的队列研究
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211008986. doi: 10.1177/10760296211008986.
3
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients.慢性抗凝和抗血小板药物使用与新型冠状病毒肺炎（SARS-CoV-2）感染患者疾病严重程度的关联。
J Thromb Thrombolysis. 2021 Aug;52(2):476-481. doi: 10.1007/s11239-021-02383-w. Epub 2021 Feb 1.
4
COVID-19 and Risk of VTE in Ethnically Diverse Populations.新冠病毒肺炎与不同种族人群静脉血栓栓塞症的风险
Chest. 2021 Oct;160(4):1459-1470. doi: 10.1016/j.chest.2021.07.025. Epub 2021 Jul 19.
5
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.新型冠状病毒2型感染与手术后静脉血栓栓塞：一项国际前瞻性队列研究。
Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24.
6
Racial Disparities in COVID-19 Testing and Outcomes : Retrospective Cohort Study in an Integrated Health System.COVID-19 检测和结果的种族差异：综合卫生系统中的回顾性队列研究。
Ann Intern Med. 2021 Jun;174(6):786-793. doi: 10.7326/M20-6979. Epub 2021 Feb 9.
7
Risk of venous thromboembolism in COVID-19 infection.COVID-19 感染中的静脉血栓栓塞风险。
Intern Med J. 2023 Aug;53(8):1478-1480. doi: 10.1111/imj.16145. Epub 2023 Jul 14.
8
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.2021 年 3 月至 7 月，加利福尼亚州大型综合医疗保健系统中 SARS-CoV-2 变异株的分布情况。
MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1415-1419. doi: 10.15585/mmwr.mm7040a4.
9
Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration Hospitals.COVID-19 住院患者在退伍军人健康管理局医院中的静脉血栓栓塞症。
Am Heart J. 2021 Jul;237:1-4. doi: 10.1016/j.ahj.2021.03.010. Epub 2021 Mar 18.
10
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.COVID-19 住院患者有症状静脉血栓栓塞的临床特征和危险因素：一项多中心回顾性研究。
J Thromb Haemost. 2021 Apr;19(4):1038-1048. doi: 10.1111/jth.15261. Epub 2021 Feb 24.
引用本文的文献
1
Tuberculosis in Pregnant Women After COVID-19: Features of Prevention, Diagnosis, and Treatment (Narrative Review).新冠疫情后孕妇的结核病：预防、诊断和治疗特点（叙述性综述）
J Clin Med. 2025 Aug 11;14(16):5681. doi: 10.3390/jcm14165681.
2
Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy.低分子量肝素与阿哌沙班（直接口服抗凝剂）在预防腹腔镜袖状胃切除术后静脉血栓栓塞方面的比较。
Obes Surg. 2025 Mar;35(3):934-940. doi: 10.1007/s11695-025-07721-y. Epub 2025 Feb 8.
3
Creating pragmatic, rapid-cycle, evidence-based innovation: The Kaiser Permanente Northern California Delivery Science and Applied Research (DARE) program.创造实用、快速循环、基于证据的创新：北加利福尼亚凯撒医疗集团的交付科学与应用研究（DARE）项目。
Learn Health Syst. 2024 May 6;9(1):e10424. doi: 10.1002/lrh2.10424. eCollection 2025 Jan.
4
COVID-19-Related Spinal Subdural Hematoma Presented with Acute Compressive Myelopathy with a Review of the Literature.新型冠状病毒肺炎相关的脊髓硬膜下血肿伴急性压迫性脊髓病并文献复习
Case Rep Neurol. 2024 Nov 29;16(1):294-303. doi: 10.1159/000528310. eCollection 2024 Jan-Dec.
5
Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk.评估2019冠状病毒病（COVID-19）疫苗接种和感染变异株对COVID-19后静脉血栓形成或栓塞风险的影响。
Open Forum Infect Dis. 2024 Sep 23;11(11):ofae557. doi: 10.1093/ofid/ofae557. eCollection 2024 Nov.
6
Symptomatic Venous Thromboembolic Events in COVID-19 Patients after Hospital Discharge: Aspects to Consider.新冠病毒感染患者出院后有症状的静脉血栓栓塞事件：需考虑的方面
Rev Cardiovasc Med. 2022 Jun 20;23(6):219. doi: 10.31083/j.rcm2306219. eCollection 2022 Jun.
7
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database.代偿期肝硬化患者感染新型冠状病毒2的血栓形成长期后果：美国数据库的倾向评分匹配分析
Diseases. 2024 Jul 17;12(7):161. doi: 10.3390/diseases12070161.
8
Multidisciplinary Management Strategies for Long COVID: A Narrative Review.长新冠的多学科管理策略：一项叙述性综述
Cureus. 2024 May 1;16(5):e59478. doi: 10.7759/cureus.59478. eCollection 2024 May.
9
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.评估非住院 COVID-19 患者的静脉血栓栓塞风险。
JAMA Netw Open. 2023 Mar 1;6(3):e232338. doi: 10.1001/jamanetworkopen.2023.2338.
10
The Cardiovascular Manifestations of COVID-19.新型冠状病毒肺炎的心血管系统表现。
Heart Fail Clin. 2023 Apr;19(2):153-161. doi: 10.1016/j.hfc.2022.08.001.
Zotero 插件